Econach Holdings
3521
Generation Pass
3195
JP-HOLDINGS
2749
Smile Holdings
7084
adish
7093
JP Stock MarketDetailed Quotes
4563 AnGes
- 75
- -1-1.32%
20min DelayMarket Closed Feb 26 15:30 JST
22.86BMarket Cap-0.63P/E (Static)
78High72Low13.10MVolume75Open76Pre Close979.15MTurnover9852wk High4.83%Turnover Ratio304.83MShares4352wk Low-119.53EPS TTM20.33BFloat Cap5596Historical HighLossP/E (Static)271.07MShs Float43Historical Low-119.53EPS LYR7.90%Amplitude--Dividend TTM8.36P/B100Lot Size--Div YieldTTM
About AnGes Company
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.
Company Profile
Symbol4563
Company NameAnGes
Founded1999-12-17
MarketTSE Growth
Employees62
Fiscal Year Ends12-31
Address7-7-15, Saito-asagi 4F, Saito Bio-Incubator
Zip Code108-0014
Phone---
Websitewww.anges.co.jp
Company Executives
- Name
- Position
- Salary
- Ei Yamada
- Representative Director , President and Chief Executive Officer
- --
- Shoya Satou
- Director
- --
- Norikazu Eiki
- Independent Director
- --
- Makoto Hara
- Independent Director
- --
- Kimiko Murofushi
- Independent Director
- --
- Junichi Komamura
- Independent Director
- --